AdamC.BergerMD

Breast, Melanoma, Surgical Oncology (Other than Breast)

Professor, Surgery, Chief of Melanoma and Soft Tissue Surgical Oncology; Associate Director for Shared Resources. Rutgers Cancer Institute of New Jersey

Join to view full profile

Dr. Berger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Berger's full profile

Already have an account?

Office
195 Little Albany St Ste 1134
New Brunswick, NJ 08901
Phone+1 732-235-7615

Fax+1 732-235-6797

Summary

Dr. Adam Berger is a general surgeon in New Brunswick, NJ and is affiliated with Robert Wood Johnson University Hospital. He received his medical degree from NYU School of Medicine and has been in practice 22 years. He specializes in breast, melanoma, and surgical oncology (other than breast) and is experienced in esophageal cancer, gastric cancer, soft tissue sarcomas, and surgical oncology including breast.

Education & Training

Temple University Hospital/Fox Chase Cancer CenterFellowship, Complex General Surgical Oncology, 2002 - 2004
University of MarylandResidency, Surgery, 1995 - 2002
New York University School of MedicineClass of 1995

Certifications & Licensure

NJ State Medical License 2019 - 2025
PA State Medical License 2002 - 2024
MD State Medical License 1997 - 2000
American Board of Surgery Surgery

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Fellow (FACS) American College of Surgeons

Clinical Trials

A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy Start of enrollment: 2006 May 25
Terminated
Not Applicable
Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer Start of enrollment: 2008 Sep 01
Completed
Phase 3
An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas Start of enrollment: 2008 Aug 01
Unknown status
Not Applicable
Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer Start of enrollment: 2010 May 26
Completed
Phase 1
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer Start of enrollment: 2011 Dec 01
Unknown status
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Start of enrollment: 2013 May 21
Completed
Phase 2
Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer Start of enrollment: 2013 Apr 25
Completed
Phase 2
Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy Start of enrollment: 2013 Mar 08
Completed
Not Applicable
Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery Start of enrollment: 2018 Jan 17
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

63 citations
NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination W...
Theodore S. Hong, Jennifer Moughan, Michael C. Garofalo, Johanna C. Bendell, Adam C. Berger
International Journal of Radiation Oncology, Biology, Physics. 2015-09-01
417 citations
Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes
Adam C. Berger, Elin R. Sigurdson, Thomas Levoyer, Alexandra L. Hanlon, Robert J. Mayer
Journal of Clinical Oncology. 2005-12-01
44 citations
Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients
Adam C. Berger, Robert S. Davidson, J. Kevin Poitras, Indy Chabra, Richard Hope
Current Medical Research and Opinion. 2016-06-03

Journal Articles

Persistently Elevated Serum Lactate Levels 48 Hours Postoperatively Predict Increased Complications After Esophagectomy
Mona Taleb, Francesco Palazzo, Karen A Chojnacki, Adam C Berger, Ernest L Rosato, Journal of The American College of Surgeons
Utility of CT Imaging in a Novel Form of High‐Dose‐Rate Intraoperative Breast Radiation Therapy
Shayna L Showalter, Adam C Berger, Taryn E Hassinger, Timothy N Showalter, David R Brenin, Journal of Medical Imaging and Radiation Oncology